Acticam

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 12/12/2013

Authorisation details

Product details
Name
Acticam
Agency product number
EMEA/V/C/000138
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Ecuphar
Revision
6
Date of issue of marketing authorisation valid throughout the European Union
08/12/2008
Contact address
Legeweg 157-I
B-8020 Oostkamp
Belgium

Product information

08/12/2013 Acticam - EMEA/V/C/000138 - R/0013

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Anti inflammatory and antirheumatic products

Therapeutic indication

Oral suspension:

Dogs:

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Solution for injection:

Dogs:

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Reduction of postoperative pain and inflammation following orthopaedic and soft-tissue surgery.

Cats:

Reduction of postoperative pain after ovariohysterectomy and minor soft-tissue surgery.

Assessment history

How useful was this page?

Add your rating